|
C/NL/06/01_001
|
Suntory Flowers Limited
|
Application for renewal of consent for marketing approval under Directive 2001/18/EC (Event FLORIGENE®Moonaqua™(FLO-4Ø689-6))
|
03-07-2018
|
Ontwerpbesluit genomen
|
|
IM-MV 17-005_000
|
Erasmus MC
|
Testing the safety and efficacy of JCAR017 in patients with aggressive B cell malignancies
|
19-07-2018
|
Vergunning verleend
|
|
IM-MV 18-001_000
|
Erasmus MC
|
Open label, single dose, multi centre trial investigating an adeno associated viral vector containing a codon optimized Padua derivative of human factor IX gene (AAV5-hFIXco-Padua, AMT-061) administered to adult patients with severe or moderately severe hemophilia B.
|
05-07-2018
|
Vergunning verleend
|
|
IM-MV 18-006_000
|
AMC
|
Open-label, single-dose, multi-centre trial investigating an adeno-associated viral vector containing a codon-optimized Padua derivative of human factor IX gene (AAV5-hFIXco-Padua, AMT-061) administered to adult patients with severe or moderately-severe hemophilia B
|
|
Ontwerpbesluit genomen
|
|
IM-MV 18-007_000
|
Universitair Medisch Centrum Utrecht
|
Open-label, single-dose, multi-centre trial investigating an adeno-associated viral vector containing a codon-optimized Padua derivative of human factor IX gene (AAV5-hFIXco-Padua, AMT-061) administered to adult patients with severe or moderately-severe hemophilia B
|
|
Ontwerpbesluit genomen
|
|
IM-MV 18-008_000
|
UMCG
|
Open-label, single-dose, multi-centre trial investigating an adeno-associated viral vector containing a codon-optimized Padua derivative of human factor IX gene (AAV5-hFIXco-Padua, AMT-061) administered to adult patients with severe or moderately-severe hemophilia B
|
|
Ontwerpbesluit genomen
|
